( NASDAQ-NMS:SQNM )

News from Agena Bioscience A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 05, 2017, 09:17 ET Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network By Adding N-of-One

Agena Bioscience, a global provider of molecular genetic solutions and N-of-One Inc., a leader in molecular decision support for oncology, have...


Sep 27, 2017, 07:36 ET Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With The MassARRAY® System

Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new,...


Sep 19, 2017, 20:14 ET Agena Bioscience anuncia: Molecular Health será el primer proveedor de software de interpretación en MassARRAY Insights™

- Agena Bioscience anuncia que Molecular Health será el primer proveedor de software de interpretación para MassARRAY Insights™ Los proveedores...


Sep 19, 2017, 17:23 ET Agena Bioscience annonce que Molecular Health sera le premier fournisseur de logiciels d'interprétation pour MassARRAY Insights™

Les fournisseurs de MassARRAY Insights aideront à l'interprétation des résultats Agena Bioscience, fournisseur mondial de solutions de...


Sep 19, 2017, 14:15 ET Agena Bioscience gibt Molecular Health als ersten Anbieter von Interpretations-Software für MassARRAY Insights™ bekannt

Die Anbieter von MassARRAY Insights werden bei der Interpretation von Ergebnissen behilflich sein. Agena Bioscience, ein weltweiter Lieferant...


Sep 19, 2017, 07:18 ET Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights™

Agena Bioscience, a global provider of molecular genetic solutions and Molecular Health, a leader in cloud-based decision support technology for...


Aug 02, 2017, 07:23 ET MassARRAY® System Selected for Illinois State Cystic Fibrosis Screening of Newborns

Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public Health (IDPH) which will deploy Agena's MassARRAY...


Jul 18, 2017, 07:13 ET Agena Bioscience and HeartGenetics Announce Co-Marketing Alliance

Agena Bioscience today announced a co-promotion agreement leveraging its MassARRAY® DX clinical diagnostics technology with HeartGenetics' CE-IVD...


Jul 18, 2017, 07:13 ET Agena Bioscience y HeartGenetics anuncian una alianza de marketing conjunto

HEARTDECODE® Software y ensayos diseñados para utilizarse con el Sistema MassARRAY® DX Agena Bioscience hoy ha anunciado un acuerdo de...


Jul 18, 2017, 07:13 ET Agena Bioscience et HeartGenetics annoncent une alliance de comarketing

Logiciel et analyses HEARTDECODE® spécifiquement conçus pour le système MassARRAY® DX Agena Bioscience a annoncé aujourd'hui un accord de...


Jul 18, 2017, 07:13 ET Agena Bioscience und HeartGenetics kündigen Co-Marketing-Allianz an

HEARTDECODE® Software und speziell zur Verwendung mit dem MassARRAY® DX-System entwickelte Assays Agena Bioscience gab heute eine...


Jun 29, 2017, 07:53 ET Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe

Agena Bioscience today announced the European launch of the MassARRAY® System with CHIP Prep Module (CPM), marketed as a CE-IVD product under the...


Jun 20, 2017, 08:13 ET Agena Bioscience Announces Expanded Partnership with Assurex Health

Agena Bioscience today announced that Assurex Health, a wholly owned subsidiary of Myriad Genetics, Inc., has selected the MassARRAY® System for...


Mar 15, 2017, 09:00 ET Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies and Solid Tumor Tissues

Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon cancers. The UltraSEEK™...


Feb 09, 2017, 09:00 ET Multiplexed Analysis of ALK, ROS1, and RET Rearrangements in Lung Cancer Enabled by the MassARRAY® System

Agena Bioscience today announced a comparative study published in Scientific Reports highlighting the use of its mass spec-based platform for...


Aug 29, 2016, 09:00 ET Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis

Agena Bioscience today announced the successful certification of Genelex as a Certified Service Provider of the MassARRAY® technology. The...


Aug 16, 2016, 09:00 ET Agena Bioscience Expands ISO Accreditation for Genetic Testing

Agena Bioscience today announced accreditation of its Assays by Agena facility in Brisbane, Australia, under ISO/IEC 17025 in the field of...


Jul 11, 2016, 09:00 ET David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business

Agena Bioscience today announced the appointment of David Coorey as Vice President and Managing Director, EMEA. David joins Agena Bioscience from...


Mar 01, 2016, 09:00 ET Agena Bioscience and CapitalBio Technology to Develop Cost-Effective Genetic Testing for Commercial Agricultural Applications

Agena Bioscience (Agena) today announced its partnership to co-develop commercial tests with CapitalBio Technology (CapitalBio) for a variety of...


Feb 01, 2016, 09:00 ET Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China

 Agena Bioscience today announced its partnership with DaRui Biotechnology to co-develop a menu of in vitro diagnostic tests for oncology and...


Jan 11, 2016, 09:00 ET Agena Bioscience Announces the Expansion of its Headquarters in San Diego, California, to Better Serve its Growing Customer Base

Agena Bioscience today announced the expansion of its headquarters to a new site in San Diego. Located at 4755 Eastgate Mall, the new...


Oct 27, 2015, 09:01 ET Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment

 Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY® Dx PLUS assays for gene-specific mutation...


Oct 20, 2015, 09:00 ET Agena Bioscience to Present Enabling Solutions for Molecular Blood Group Genotyping at AABB 2015

 Agena Bioscience™ today announced expanded use of its MassARRAY® System for High Throughput Molecular Blood Group...


Sep 01, 2015, 09:01 ET Agena Bioscience Opens Office in Shanghai, China

Agena BioscienceTM today announced the establishment of a subsidiary in Shanghai, a commercial and financial hub from which many biotech and life...


Jun 04, 2014, 11:30 ET Agena Bioscience Introduces the Hemo ID™ Panel for Blood Group Genotyping at the 33rd International Congress of the ISBT in Seoul, Korea

Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today, introduced the Hemo ID™ Blood Group...